TREATMENT OF MRSA PNEUMONIA: ECONOMICAL AND CLINICAL COMPARISON OF LINEZOLID VERSUS VANCOMYCIN

被引：1
|
作者：
Wilke, M. [1 ]
Petrik, C. [2 ]
Weber, B. [3 ]
Kloss, S. [3 ]
机构：
[1] Dr Wilke GmbH, Munich, Germany
[2] Pfizer Pharma GmbH, Berlin, Germany
[3] Pfizer Deutschland GmbH, Berlin, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2474
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN33
引用
收藏
页码：A669 / A669
页数：1
相关论文
共 50 条
  • [1] Linezolid versus vancomycin for MRSA nosocomial pneumonia
    不详
    FUTURE MICROBIOLOGY, 2010, 5 (12) : 1763 - 1763
  • [2] The ZEPHyR study: A randomized comparison of linezolid and vancomycin for MRSA pneumonia
    Chavanet, P.
    MEDECINE ET MALADIES INFECTIEUSES, 2013, 43 (11-12): : 451 - 455
  • [3] THE EFFECT OF VANCOMYCIN AND LINEZOLID ON THE TREATMENT AND OUTCOMES OF PRESUMED MRSA PNEUMONIA
    Kinney, Justin
    Pop, Lia
    Lowe, Andrew
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [4] COMPARISON OF TEDIZOLID, LINEZOLID, AND VANCOMYCIN FOR MRSA PNEUMONIA IN A NEUTROPENIC MOUSE MODEL
    Kidd, James
    Abdelraouf, Kamilia
    Nicolau, David
    CRITICAL CARE MEDICINE, 2019, 47
  • [5] Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia
    Huon, J. F.
    Boutoille, D.
    Caillon, J.
    Orain, J.
    Crochette, N.
    Potel, G.
    Abgueguen, P.
    Moal, F.
    Navas, D.
    MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (03): : 252 - 256
  • [6] COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC
    Pettigrew, M.
    Thirion, D. J.
    Libman, M.
    Zanotti, G.
    VALUE IN HEALTH, 2011, 14 (03) : A116 - A116
  • [7] Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
    Mathias W Pletz
    Olaf Burkhardt
    Tobias Welte
    European Journal of Medical Research, 15
  • [8] NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) PNEUMONIA LINEZOLID OR VANCOMYCIN? - COMPARISON OF PHARMACOLOGY AND CLINICAL EFFICACY
    Pletz, Mathias W.
    Burkhardt, Olaf
    Welte, Tobias
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 507 - 513
  • [9] The Effects of Obesity on the Comparative Effectiveness of Linezolid and Vancomycin in MRSA Pneumonia
    Caffrey, Aisling R.
    Noh, Eunsun
    Morrill, Haley J.
    LaPlante, Kerry L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 16 - 17
  • [10] Effectiveness of linezolid versus vancomycin treatment for MRSA skin and soft tissue infections
    Yim, M.
    Steingisser, J.
    Kan, R.
    Nshala, A.
    Larson, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E394 - E394
12345